Five-year relative survival for acute lymphoblastic leukaemia (ALL) in men in England (38%) is similar to the average for Europe (39%). Wales (40%) and Scotland (37%) are also similar to the European average. No five-year survival data is available for Northern Ireland. Across the European countries for which data is available, five-year relative survival in men ranges from 16% (Bulgaria) to 47% (Ireland).
Five-year relative survival for ALL in women in England (35%) is similar to the average for Europe (40%). Wales (40%), Scotland (42%) and Northern Ireland (41%) are also similar to the European average. Across the European countries for which data is available, five-year relative survival in women ranges from 23% (Bulgaria) to 53% (Sweden).
Acute Lymphoblastic Leukaemia (C91.0), Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries, 2000-2007
Data consists of both observed and predicted 5-year relative survival. Where sufficient follow-up was not available for recently diagnosed patients the period approach was used to predict 5-year cohort survival.
Possible explanations for persistent international differences in survival include differences in cancer biology, use of diagnostic tests and screening, stage at diagnosis, access to high-quality care, and data collection practices.
- De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol 2014;15:23-34
About this data
Data is for: 29 European countries, patients diagnosed in 2000-2007 and followed up to 2008, acute lymphatic leukaemia (C91.0).